Jason Camm - 10 Sep 2021 Form 4/A - Amendment Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Director
Signature
/s/ Ryan Barrett, Attorney-in-fact
Issuer symbol
ATAI
Transactions as of
10 Sep 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
14 Oct 2021, 17:31:32 UTC
Date Of Original Report
13 Sep 2021
Previous filing
17 Jun 2021
Next filing
03 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ATAI Stock Option 0 10 Sep 2021 Common Shares 0 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 13, 2021, a Form 4 was inadvertently filed reporting a stock option award to purchase 128,000 common shares that did not in fact occur. The Reporting Person does not own any tranche of stock options.